Two patterns of macrolide resistance, constitutive resistance and inducible or dissociated resistance, are known to occur in staphylococci (3, 7) and streptococci (9). These resistances are also involved with the lincosamide and streptogramin group B antibiotics (1, 2, 21). Another pattern of streptogramin resistance in Staphylococcus aureus, in which both A and B groups of the compound are involved, has been reported (4). The resistant strain was able to inactivate pristinamycin, a member of the streptogramin class of antibiotics.
Different patterns of resistance against commonly used macrolide, lincosamide, and streptogramin antibiotics were found in Clostridium perfringens of animal origin. The patterns were designated as (i) macrolide-lincosamide-streptogramin group B generalized resistance, (ii) macrolide-lincosamide generalized resistance, (iii) macrolide-lincosamide inducible resistance, and (iv) macrolide-lincosamidestreptogramin low-level generalized resistance. The strains of the fourth pattern were able to inactivate pristinamycin and virginiamycin. The macrolide-susceptible strains showed a bimodal distribution of lincomycin and clindamycin susceptibility levels. The susceptible strains were inhibited by 0.25 Mg of lincomycin per ml and 0.03 Mig of clindamycin per ml. The low-level resistant strains were inhibited at concentrations of 2 to 4 Mg of lincomycin per ml and 0.5 to 2 Mg of cindamycin per ml.
Two patterns of macrolide resistance, constitutive resistance and inducible or dissociated resistance, are known to occur in staphylococci (3, 7) and streptococci (9) . These resistances are also involved with the lincosamide and streptogramin group B antibiotics (1, 2, 21) . Another pattern of streptogramin resistance in Staphylococcus aureus, in which both A and B groups of the compound are involved, has been reported (4). The resistant strain was able to inactivate pristinamycin, a member of the streptogramin class of antibiotics.
Resistance of Clostridium perfringens to erythromycin, lincomycin, or clindamycin has been reported (13, 15, 24) . The The resistant strains were also tested with the Gots tests (8) to determine whether they were able to inactivate the antibiotics. S. aureus ATCC 25923, with MICs of 0.12 yg/ml, 0.25 ,Lg/ml, 0.12 Ag/ml, 4 ,ug/ml, and 10,ug/ml against erythromycin, lincomycin, pristinamycin, virginiamycin component M, and virginiamycin component S, respectively, was used to seed the antibiotic-containing agar. Wilkins-Chalgren agar was melted and then cooled to about 45°C. Suspension of a 20-h agar culture of S. aureus was made in phosphate-buffered saline to match the turbidity of the no. 2 McFarland standard. One milliliter of the suspension was added to 100 ml of melted agar, mixed thoroughly, and poured in petri plates containing measured quantities of antibiotic dilutions to make a final concentration of 0.25, 0.5, and 1 .tg of erythromycin per ml, 0.5, 1, and 2 ug of lincomycin per ml, 0.25, 0.5, and 1 ,ug of pristinamycin per ml, 5, 7.5, and 10 After 48 h of incubation anaerobically in GasPak jars at 37°C, the results were noted. A zone of satellite colonies of S. aureus in the agar under the surface growth extending both toward the center of the bacterial surface growth and around its periphery was recorded as positive, indicating inactivation of the antibiotics by the tested strains. Absence of growth of S. aureus was recorded as negative.
Tests to assess degradation of antibiotics in broth. The standard curve for virginiamycin component M was obtained by carrying out the agar diffusion assay method as described by Sabath and Matsen (14) , using Micrococcus luteus ATCC 9341. Two strains out of the three that showed the evidence of inactivation of antibiotics in the Gots tests were tested. The strains were inoculated in 10 ml of Wilkins-Chalgren broth containing 30 ,ug of virginiamycin component M per ml and incubated anaerobically. An uninoculated control tube containing the same amounts of media and antibiotics was also incubated with the inoculated tubes. After 16 and 24 h of incubation, 1 ml of medium from each tube was pipetted out, mixed with 2 ml of acetone, and kept at -20°C in airtight containers. After overnight preservation, the potency of antibiotic in the media was measured in M. luteus-seeded DST agar, using 0.02-ml-loaded 6- The fourth pattern of resistance, designated MLS low-level generalized resistance, was found in strains from cattle only. The MICs of the tested macrolides and lincosamides against these strains were not as high as those described earlier. The strains were resistant to both groups of streptogramin. They were able to inactivate pristinamycin and virginiamycin components M and S in Gots tests. Pristinamycin was inactivated up to a concentration of 0.5 ,ug/ml. Although the strains were able to grow at a concentration of 1 ,ug/ml, the inactivation was not sufficient to allow the seed strain, S. aureus ATCC 25923, with a pristinamycin MIC of 0.12 ,tg/ml, to grow.
The two strains tested in broth were also able to inactivate virginiamycin component M in 16 h. This drug inactivation capability of the strains suggests an enzymatic mechanism of resistance. An acetyl-transferase and a hydrolase capable of inactivating pristinamycin 2A (11) and pristinamycin 1A (10), respectively, have been described in a strain of S. aureus.
An unusual trimodal distribution of lincomycin and clindamycin susceptibility levels was found. The strains investigated in this study can be classified into three groups: (i) a susceptible group, (ii) a low-level resistant or intermediate group, and (iii) a resistant group which includes the macrolide and streptogramin cross-resistant strains. Strains of the first two groups were susceptible to the macrolide antibiotics. A similar trimodal distribution of lincomycin susceptibility levels has been reported in C. perfringens strains from humans (15) . It is remarkable that similar percentages of susceptible, low-level resistaint or intermediate, and resistant strains against lincosamides occur in host species as different as humans, pigs, and cattle.
The three classes of antimicrobial agents investigated in this study are inhibitors of the 50S ribosomal subunit (22) . Toxigenic types of C. perfringens have been shown to carry plasmid ribonucleic acid (5). Sebald and co-workers (16) reported the isolation of a resistant strain of C. perfringens where the resistance against erythromycin and clindamycin appeared to be coded for by a plasmid, pIP402. This R plasmid was not transferable to other C. perfringens strains (17) .
The significance of the resistance patterns reported here is a inatter of speculation. Some of the observed resistance patterns appear to be similar to those found in other bacterial species, but their relationship is unknown. It is also not known whether animal C. perfringens frequently colonize humans. All strains studied here were susceptible to penicillins (G. N. Dutta and L. A. Devriese, J. Vet. Pharmacol. Ther., in press), the antibiotics of choice in the treatment of clostridial infections. When C. perfringens strains with the resistance patterns reported here cause disease in animals, it is unlikely that they will respond to treatment with the MLS antibiotics.
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